BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34874751)

  • 1. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
    Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
    J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
    Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable?
    Zhou S; Gomulia E; Mascarenhas L; Wang L
    Hum Pathol; 2015 Apr; 46(4):620-4. PubMed ID: 25649007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
    J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors.
    Trobaugh-Lotrario AD; Tomlinson GE; Finegold MJ; Gore L; Feusner JH
    Pediatr Blood Cancer; 2009 Mar; 52(3):328-34. PubMed ID: 18985717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731.
    Vasudevan SA; Meyers RL; Finegold MJ; López-Terrada D; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; Malogolowkin MH; Krailo MD; Piao J; Randazzo J; Towbin AJ; BethMcCarville M; O'Neill AF; Furman WL; Rodriguez-Galindo C; Katzenstein HM
    J Pediatr Surg; 2022 Oct; 57(10):251-256. PubMed ID: 35810020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
    Meyers RL; Rowland JR; Krailo M; Chen Z; Katzenstein HM; Malogolowkin MH
    Pediatr Blood Cancer; 2009 Dec; 53(6):1016-22. PubMed ID: 19588519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC).
    Trobaugh-Lotrario AD; Maibach R; Aronson DC; Rangaswami A; Häberle B; O'Neill AF; Schmid I; Ansari M; Hishiki T; Ranganathan S; Alaggio R; de Krijger RR; Tanaka Y; Cho SJ; Vokuhl C; Maxwell R; Krailo M; Hiyama E; Czauderna P; Finegold M; Feusner JH; Malogolowkin MH; Meyers RL; Lopez-Terrada D
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
    Katzenstein HM; Furman WL; Malogolowkin MH; Krailo MD; McCarville MB; Towbin AJ; Tiao GM; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Rodriguez-Galindo C; Meyers RL
    Cancer; 2017 Jun; 123(12):2360-2367. PubMed ID: 28211941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
    Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
    JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
    Hiyama E; Hishiki T; Watanabe K; Ida K; Ueda Y; Kurihara S; Yano M; Hoshino K; Yokoi A; Takama Y; Nogami Y; Taguchi T; Mori M; Kihira K; Miyazaki O; Fuji H; Honda S; Iehara T; Kazama T; Fujimura J; Tanaka Y; Inoue T; Tajiri T; Kondo S; Oue T; Yoshimura K
    J Clin Oncol; 2020 Aug; 38(22):2488-2498. PubMed ID: 32421442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.
    Maibach R; Roebuck D; Brugieres L; Capra M; Brock P; Dall'Igna P; Otte JB; De Camargo B; Zsiros J; Zimmermann A; Aronson D; Childs M; Scopinaro M; Morland B; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Jul; 48(10):1543-9. PubMed ID: 22244829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
    Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
    Dall'Igna P; Brugieres L; Christin AS; Maibach R; Casanova M; Alaggio R; de Goyet JV; Zsiros J; Morland B; Czauderna P; Childs M; Aronson DC; Branchereau S; Brock P; Perilongo G
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
    Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
    Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
    Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
    Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
    J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.